IMPORTANT SAFETY INFORMATION
OMIDRIA must be added to irrigation solution prior to
intraocular use. OMIDRIA is contraindicated in patients
with a known hypersensitivity to any of its ingredients.
Systemic exposure of phenylephrine may cause elevations
in blood pressure.
Use OMIDRIA with caution in individuals who have previously
exhibited sensitivities to acetylsalicylic acid, phenylacetic
acid derivatives, and other non-steroidal anti-infl ammatories
(NSAIDs), or have a past medical history of asthma.
The most commonly reported adverse reactions at 2-24%
are eye irritation, posterior capsule opacifi cation, increased
intraocular pressure, and anterior chamber infl ammation.
Use of OMIDRIA in children has not been established.
You are encouraged to report suspected adverse
reactions to the FDA. Visit www.fda.gov/medwatch,
or call 1-800-FDA-1088.
INDICATIONS AND USAGE
OMIDRIA is added to ophthalmic irrigation solution used during
cataract surgery or intraocular lens replacement and is indicated
for maintaining pupil size by preventing intraoperative miosis
and reducing postoperative ocular pain.
Please see the Full Prescribing Information for OMIDRIA
at www.omidria.com/prescribinginformation
*Provides fi nancial support to your patient by covering the
difference between your facility's acquisition cost for
OMIDRIA and the amount paid by
your patient's insurance company
(less a $30 patient responsibility).
Reference: 1. OMIDRIA [package insert]. Seattle, WA:
Omeros Corporation; 2015.
OMEROS
®
, OMIDRIA
®
, and the OMIDRIA logo
®
are registered trademarks, and OMIDRIAssure
™
is a trademark, of Omeros Corporation.
© Omeros Corporation 2015,
all rights reserved. 2015-213
Now you can provide the benefi ts of OMIDRIA—
without worrying about coverage and reimbursement
Assistance for fi nancially
eligible uninsured or
government-insured
patients
"EQUAL
ACCESS"
PATIENT
ASSISTANCE
PROGRAM
Personalized services
to assist your offi ce with
reimbursement related
to OMIDRIA
Assistance for patients
with insuffi cient
commercial insurance
LIVE
ASSISTANCE
INFORMATION
HOTLINE
"WE PAY THE
DIFFERENCE"
COMMERCIAL
REIMBURSEMENT
PROGRAM*
Because every patient deserves access to OMIDRIA...
Enroll your next cataract surgery patient in OMIDRIAssure now!
Talk to your OMIDRIA representative today or call 1-877-OMIDRIA (1-877-664-3742)
to access your Patient Enrollment Form, or download it at
www.OMIDRIA.com
Introducing
OMIDRIA® (phenylephrine and ketorolac injection) 1% / 0.3%
IS COVERED FOR MORE CATARACT
SURGERY PATIENTS THAN YOU THINK
Miosis prevention and post-op ocular pain reduction in one
1
LEARN MORE AT
AAO 2015
BOOTH
#3871